IWP
REGN icon

Icon Wealth Partners’s Regeneron Pharmaceuticals REGN Stock Holding History

Icon Wealth Partners’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$277K Hold
336
– – 0.03% 246
2023
Q2 		$241K Buy
336
+6
+2% +$4.63K 0.03% 290
2023
Q1 		$271K Buy
+330
New +$249K 0.03% 266
2022
Q2 		$229K Sell
387
-64
-14% -$41.6K 0.03% 278
2022
Q1 		$315K Sell
451
-12
-3% -$7.59K 0.03% 264
2021
Q4 		$292K Sell
463
-6
-1% -$3.69K 0.03% 264
2021
Q3 		$284K Sell
469
-2
-0.4% -$1.24K 0.03% 290
2021
Q2 		$263K Sell
471
-6
-1% -$3.04K 0.03% 316
2021
Q1 		$226K Sell
477
-2,902
-86% -$1.41M 0.03% 308
2020
Q4 		$1.63M Buy
3,379
+618
+22% +$334K 0.26% 86
2020
Q3 		$1.55M Buy
2,761
+2,095
+315% +$1.27M 0.3% 83
2020
Q2 		$415K Buy
666
+7
+1% +$3.97K 0.1% 144
2020
Q1 		$322K Buy
659
+24
+4% +$9.9K 0.13% 94
2019
Q4 		$238K Buy
+635
New +$214K 0.08% 149
2019
Q2 		– Sell
-344
Closed -$141K – 625
2019
Q1 		$141K Buy
344
+30
+10% +$12.4K 0.05% 183
2018
Q4 		$117K Sell
314
-14
-4% -$5.12K 0.06% 196
2018
Q3 		$133K Buy
328
+4
+1% +$1.52K 0.06% 221
2018
Q2 		$112K Buy
+324
New +$101K 0.05% 221
2018
Q1 		– Sell
-206
Closed -$77K – 624
2017
Q4 		$77K Buy
+206
New +$83.4K 0.04% 320

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Icon Wealth Partners's REGN Position: Q3 2023 in Review

Icon Wealth Partners held its Regeneron Pharmaceuticals (REGN) position steady in Q3 2023 at 336 shares worth $277K. The position accounts for 0.03% of the portfolio, ranked #246.

Icon Wealth Partners first reported a position in REGN in Q4 2017 and has held it in 19 quarters since. The position peaked at $1.63M in Q4 2020. 1,177 funds tracked by Wall St. Rank hold REGN as of Q3 2023.

  • Icon Wealth Partners held 336 shares of Regeneron Pharmaceuticals worth $277K as of Q3 2023.
  • Icon Wealth Partners left its Regeneron Pharmaceuticals share count unchanged in Q3 2023.
  • Regeneron Pharmaceuticals made up 0.03% of Icon Wealth Partners's portfolio in Q3 2023, its #246 holding.
  • Icon Wealth Partners first reported a position in Regeneron Pharmaceuticals in Q4 2017 and has held it in 19 quarters since.
  • Icon Wealth Partners's Regeneron Pharmaceuticals position peaked at $1.63M in Q4 2020.
  • 1,177 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2023.

Based on Icon Wealth Partners's 13F filing for Q3 2023, filed 14 Nov 2023.